“Biopharma manufacturers are focused on maximizing productivity, accelerating time-to-market and generating efficiencies all while improving the overall sustainability of their operations,” Ray Mercier, president of Thermo Fisher’s single-use technologies business, said in a press statement. “Our biobased films allow customers to reduce their environmental impact without having to validate new BPCs, helping them bring treatments to patients faster while also helping to protect the planet.”
Biopharma manufacturers can pre-purchase the biobased films now to incorporate into their upstream or downstream system in early 2025.